Selected research publications
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY) a randomised, controlled, open-label, platform trial – Journal: The Lancet Infectious Diseases – Published: 1st September 2025
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – Journal: The Lancet Infectious Diseases – Published: 28th August 2025
Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19 – Journal: Journal of Infectious Disease – Published: 15th July 2024
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses – Journal: Nature Communications – Published: 22nd December 2023
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection – Journal: Genome Biology – Published: 1st December 2023
View more publications